カテゴリ： GlobalData, イギリス, 企業調査

LivaNova PLC (LIVN)：製品パイプライン分析

◆英語タイトル：LivaNova PLC (LIVN) - Product Pipeline Analysis, 2017 Update
◆商品コード：DATA8010077
◆発行会社（調査会社）：GlobalData
◆発行日：2017年12月27日
◆ページ数：82
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：イギリス
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD1,500 ⇒換算￥222,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD2,250 ⇒換算￥333,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
LivaNova PLC (LivaNova) is a medical technology company that offers medical devices for cardiac surgery, neuromodulation and cardiac rhythm management. The company’s neuromodulation segment provides vagus nerve stimulation therapy system, an implantable device for the people affected by treatment-resistant epilepsy, depression, heart failure and other chronic disorders. Its cardiovascular surgery products include oxygenators, heart-lung machines, perfusion tubing systems, cannulae and accessories; systems for autotransfusion and autologous blood washing; surgical tissue and mechanical valve replacements, and repair products for damaged or diseased heart valves. LivaNova offers cardiac rhythm management products such as implantable cardiac pacemakers, cardioverter defibrillators, cardiac resynchronization therapy devices, and patient management tools. The company offers its solutions to patients, healthcare professionals and healthcare systems. LivaNova is headquartered in London, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company LivaNova PLC
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
LivaNova PLC Company Overview 8
LivaNova PLC Company Snapshot 8
LivaNova PLC Pipeline Products and Ongoing Clinical Trials Overview 8
LivaNova PLC – Pipeline Analysis Overview 11
LivaNova PLC – Key Facts 11
LivaNova PLC – Major Products and Services 12
LivaNova PLC Pipeline Products by Development Stage 13
LivaNova PLC Ongoing Clinical Trials by Trial Status 17
LivaNova PLC Pipeline Products Overview 19
3rd Generation Bicarbon Heart Valve 19
3rd Generation Bicarbon Heart Valve Product Overview 19
Aspire NP 20
Aspire NP Product Overview 20
Beflex Brady Lead 21
Beflex Brady Lead Product Overview 21
Caisson TMVR System 22
Caisson TMVR System Product Overview 22
Caisson TMVR System Clinical Trial 23
Centro Generator 24
Centro Generator Product Overview 24
CentroSR Generator 25
CentroSR Generator Product Overview 25
Equilia 26
Equilia Product Overview 26
Equilia Clinical Trial 27
Griffin – Pulse Generator 28
Griffin – Pulse Generator Product Overview 28
Intense Neuromodulation – Heart Failure 29
Intense Neuromodulation – Heart Failure Product Overview 29
LBATS 30
LBATS Product Overview 30
Nano Lead System 31
Nano Lead System Product Overview 31
NAVIGO 4LV 2D 32
NAVIGO 4LV 2D Product Overview 32
NAVIGO 4LV 2D Clinical Trial 33
NAVIGO 4LV ARC 34
NAVIGO 4LV ARC Product Overview 34
NAVIGO 4LV ARC Clinical Trial 35
NAVIGO 4LV PILOT 36
NAVIGO 4LV PILOT Product Overview 36
NAVIGO 4LV PILOT Clinical Trial 37
Nerve Wrap 38
Nerve Wrap Product Overview 38
New Oxy Apex HP Oxygenator 39
New Oxy Apex HP Oxygenator Product Overview 39
Next Generation ECMO System 40
Next Generation ECMO System Product Overview 40
Next Generation Wand – VNS Therapy 41
Next Generation Wand – VNS Therapy Product Overview 41
NINO 42
NINO Product Overview 42
Paradym CRT-D Tri-V Device 43
Paradym CRT-D Tri-V Device Product Overview 43
Paradym CRT-D Tri-V Device Clinical Trial 44
Paradym RF Platform 45
Paradym RF Platform Product Overview 45
PARADYM RF SonR CRT-D 46
PARADYM RF SonR CRT-D Product Overview 46
PARADYM RF SonR CRT-D Clinical Trial 47
Perceval S – Extended Indications 48
Perceval S – Extended Indications Product Overview 48
Perceval S – Extended Indications Clinical Trial 49
Perceval Sutureless Aortic Valve – XL Version 50
Perceval Sutureless Aortic Valve – XL Version Product Overview 50
Perceval Sutureless Aortic Valve – XL Version Clinical Trial 51
Perceval Sutureless Heart Valve 52
Perceval Sutureless Heart Valve Product Overview 52
Perceval Sutureless Heart Valve Clinical Trial 53
Perceval Valve MIS Introducer 54
Perceval Valve MIS Introducer Product Overview 54
Percutaneous Mitral Valve Repair Device 55
Percutaneous Mitral Valve Repair Device Product Overview 55
Percutaneous Mitral Valve Replacement Device 56
Percutaneous Mitral Valve Replacement Device Product Overview 56
PhoenixRF SR 57
PhoenixRF SR Product Overview 57
ProGuardian System 58
ProGuardian System Product Overview 58
Remote Monitoring System V2 59
Remote Monitoring System V2 Product Overview 59
Reply CRT-P 60
Reply CRT-P Product Overview 60
Reply MRI Pacemaker 61
Reply MRI Pacemaker Product Overview 61
Second Generation Vagus Nerve Stimulator 62
Second Generation Vagus Nerve Stimulator Product Overview 62
SonR Tist Lead Positioning 63
SonR Tist Lead Positioning Product Overview 63
SonRFix Lead 64
SonRFix Lead Product Overview 64
Spiderflash AFIB 65
Spiderflash AFIB Product Overview 65
Tachy Lead 66
Tachy Lead Product Overview 66
Triple-Site Ventricular (Tri-V) Pacing CRT-D 67
Triple-Site Ventricular (Tri-V) Pacing CRT-D Product Overview 67
TX Brady Lead 68
TX Brady Lead Product Overview 68
LivaNova PLC – Key Competitors 69
LivaNova PLC – Key Employees 70
LivaNova PLC – Locations And Subsidiaries 71
Head Office 71
Other Locations & Subsidiaries 71
Recent Developments 72
LivaNova PLC , Recent Developments 72
Nov 02, 2017: LivaNova Reports Third Quarter 2017 Results 72
Oct 17, 2017: Phoenix Children’s Hospital is the First in Arizona to Offer New Epilepsy Treatment 73
Oct 09, 2017: LivaNova Receives FDA Approvals for SenTiva Device and Next-Generation VNS Therapy Programming System for Treatment of Epilepsy 73
Oct 02, 2017: LivaNova Announces One-Millionth Patient Treated with Advanced XTRA Autotransfusion System 74
Sep 25, 2017: LivaNova Announces U.S. Launch of Optiflow Arterial Cannulae Family 74
Sep 14, 2017: LivaNova to Explore Strategic Options for Cardiac Rhythm Management Business Franchise 75
Sep 11, 2017: LivaNova Announces Publication of Literature Review Highlighting the Clinical Value and Safety of the Perceval Sutureless Valve for Aortic Valve Replacement 75
Aug 09, 2017: LivaNova Reports Second Quarter 2017 Results 76
Aug 07, 2017: LivaNova Implements 3T Heater-Cooler Device Modification 77
Aug 04, 2017: LivaNovas Perceval Sutureless Aortic Heart Valve Awarded New Technology Add-on Payment from the Center for Medicare and Medicaid Services 77
Appendix 79
Methodology 79
About GlobalData 81
Contact Us 81
Disclaimer 82

List of Tables
LivaNova PLC Pipeline Products and Ongoing Clinical Trials Overview 8
LivaNova PLC Pipeline Products by Equipment Type 9
LivaNova PLC Pipeline Products by Indication 10
LivaNova PLC Ongoing Clinical Trials by Trial Status 10
LivaNova PLC , Key Facts 11
LivaNova PLC , Major Products and Services 12
LivaNova PLC Number of Pipeline Products by Development Stage 13
LivaNova PLC Pipeline Products Summary by Development Stage 14
LivaNova PLC Ongoing Clinical Trials by Trial Status 17
LivaNova PLC Ongoing Clinical Trials Summary 18
3rd Generation Bicarbon Heart Valve - Product Status 19
3rd Generation Bicarbon Heart Valve - Product Description 19
Aspire NP - Product Status 20
Aspire NP - Product Description 20
Beflex Brady Lead - Product Status 21
Beflex Brady Lead - Product Description 21
Caisson TMVR System - Product Status 22
Caisson TMVR System - Product Description 22
Caisson TMVR System - Percutaneous Mitral Valve Replacement Evaluation Utilizing IDE Early Feasibility Study (PRELUDE) 23
Centro Generator - Product Status 24
Centro Generator - Product Description 24
CentroSR Generator - Product Status 25
CentroSR Generator - Product Description 25
Equilia - Product Status 26
Equilia - Product Description 26
Equilia - Vagal Nerve Stimulation: Safe-guarding Heart Failure Patients (VANGUARD) 27
Griffin - Pulse Generator - Product Status 28
Griffin - Pulse Generator - Product Description 28
Intense Neuromodulation - Heart Failure - Product Status 29
Intense Neuromodulation - Heart Failure - Product Description 29
LBATS - Product Status 30
LBATS - Product Description 30
Nano Lead System - Product Status 31
Nano Lead System - Product Description 31
NAVIGO 4LV 2D - Product Status 32
NAVIGO 4LV 2D - Product Description 32
NAVIGO 4LV 2D - Safety and Electrical Performances Evaluation of Navigo Leads Equipped with IS4 Connector 33
NAVIGO 4LV ARC - Product Status 34
NAVIGO 4LV ARC - Product Description 34
NAVIGO 4LV ARC - Safety and Electrical Performances Evaluation of Navigo Leads Equipped with IS4 Connector 35
NAVIGO 4LV PILOT - Product Status 36
NAVIGO 4LV PILOT - Product Description 36
NAVIGO 4LV PILOT - Safety and Electrical Performances Evaluation of Navigo Leads Equipped with IS4 Connector 37
Nerve Wrap - Product Status 38
Nerve Wrap - Product Description 38
New Oxy Apex HP Oxygenator - Product Status 39
New Oxy Apex HP Oxygenator - Product Description 39
Next Generation ECMO System - Product Status 40
Next Generation ECMO System - Product Description 40
Next Generation Wand - VNS Therapy - Product Status 41
Next Generation Wand - VNS Therapy - Product Description 41
NINO - Product Status 42
NINO - Product Description 42
Paradym CRT-D Tri-V Device - Product Status 43
Paradym CRT-D Tri-V Device - Product Description 43
Paradym CRT-D Tri-V Device - Triple-site Biventricular Stimulation in the Optimization of Cardiac Resynchronization Therapy (CRT) 44
Paradym RF Platform - Product Status 45
Paradym RF Platform - Product Description 45
PARADYM RF SonR CRT-D - Product Status 46
PARADYM RF SonR CRT-D - Product Description 46
PARADYM RF SonR CRT-D - Clinical Assessment of the SonR Algorithm in the PARADYM RF SonR CRT-D by Echocardiography 47
PARADYM RF SonR CRT-D - Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the PARADYM RF SonR CRT-D 47
PARADYM RF SonR CRT-D - Continued Access Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the Paradym RF SonR CRT-D 47
Perceval S – Extended Indications - Product Status 48
Perceval S – Extended Indications - Product Description 48
Perceval S – Extended Indications - Behavior of Valve Leaflets and the Incidence of Reduced Mobility Post-surgical Aortic Valve Implant 49
Perceval Sutureless Aortic Valve - XL Version - Product Status 50
Perceval Sutureless Aortic Valve - XL Version - Product Description 50
Perceval Sutureless Aortic Valve - XL Version - Behavior of Valve Leaflets and the Incidence of Reduced Mobility Post-surgical Aortic Valve Implant 51
Perceval Sutureless Aortic Valve - XL Version - Perceval Sutureless Implant Versus Standard-aortic Valve Replacement A Controlled Randomized Trial in the Surgical Treatment of Aortic Valve Disease 51
Perceval Sutureless Heart Valve - Product Status 52
Perceval Sutureless Heart Valve - Product Description 52
Perceval Sutureless Heart Valve - Behavior of Valve Leaflets and the Incidence of Reduced Mobility Post-surgical Aortic Valve Implant 53
Perceval Sutureless Heart Valve - Perceval S Valve Clinical Trial for Extended CE Mark 53
Perceval Valve MIS Introducer - Product Status 54
Perceval Valve MIS Introducer - Product Description 54
Percutaneous Mitral Valve Repair Device - Product Status 55
Percutaneous Mitral Valve Repair Device - Product Description 55
Percutaneous Mitral Valve Replacement Device - Product Status 56
Percutaneous Mitral Valve Replacement Device - Product Description 56
PhoenixRF SR - Product Status 57
PhoenixRF SR - Product Description 57
ProGuardian System - Product Status 58
ProGuardian System - Product Description 58
Remote Monitoring System V2 - Product Status 59
Remote Monitoring System V2 - Product Description 59
Reply CRT-P - Product Status 60
Reply CRT-P - Product Description 60
Reply MRI Pacemaker - Product Status 61
Reply MRI Pacemaker - Product Description 61
Second Generation Vagus Nerve Stimulator - Product Status 62
Second Generation Vagus Nerve Stimulator - Product Description 62
SonR Tist Lead Positioning - Product Status 63
SonR Tist Lead Positioning - Product Description 63
SonRFix Lead - Product Status 64
SonRFix Lead - Product Description 64
Spiderflash AFIB - Product Status 65
Spiderflash AFIB - Product Description 65
Tachy Lead - Product Status 66
Tachy Lead - Product Description 66
Triple-Site Ventricular (Tri-V) Pacing CRT-D - Product Status 67
Triple-Site Ventricular (Tri-V) Pacing CRT-D - Product Description 67
TX Brady Lead - Product Status 68
TX Brady Lead - Product Description 68
LivaNova PLC , Key Employees 70
LivaNova PLC , Subsidiaries 71
Glossary 80

★海外企業調査レポート[LivaNova PLC (LIVN)：製品パイプライン分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • WNDM Medical Inc (WNDM)：医療機器：M&Aディール及び事業提携情報
    Summary WNDM Medical Inc (WNDM Medical), formerly Wound Management Technologies Inc is a distributor of biotechnology products to hospitals, physicians, and clinics. The company offers its patented product CellerateRX in powder and gel forms, and hemaquell resorbable bone wax that controls bone blee …
  • Pharmacosmos AS：製薬・医療：M&Aディール及び事業提携情報
    Summary Pharmacosmos AS (Pharmacosmos) is a drug discovery and development company that manufactures and markets medicines for the treatment of iron deficiency anaemia in humans and animals. The company offers human iron therapy, veterinary iron therapy, pharmacosmos dextrans, pharmaceutical biopoly …
  • Fresenius Kabi AG：製薬・医療：M&Aディール及び事業提携情報
    Summary Fresenius Kabi AG (Fresenius Kabi), a wholly owned subsidiary of Fresenius SE & Co KGaA, develops, manufactures and markets pharmaceuticals products and medical devices. The company's product portfolio includes intravenously administered drugs, infusion therapy products, medical devices and …
  • IDFC Ltd (IDFC)：企業の財務・戦略的SWOT分析
    IDFC Ltd (IDFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Harte Hanks Inc (HHS)：企業の財務・戦略的SWOT分析
    Harte Hanks Inc (HHS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Kiwibank Limited：企業の戦略・SWOT・財務情報
    Kiwibank Limited - Strategy, SWOT and Corporate Finance Report Summary Kiwibank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Tipco Foods Public Company Limited ：企業の戦略・SWOT・財務情報
    Tipco Foods Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Tipco Foods Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Koppers Holdings Inc (KOP)：企業の財務・戦略的SWOT分析
    Koppers Holdings Inc (KOP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Composites Horizons, Inc.：企業の戦略・SWOT・財務情報
    Composites Horizons, Inc. - Strategy, SWOT and Corporate Finance Report Summary Composites Horizons, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Orascom Construction Plc (OC)：企業の財務・戦略的SWOT分析
    Orascom Construction Plc (OC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • A.F. Blakemore & Son Ltd (Foodservice)：企業の戦略・SWOT・財務情報
    A.F. Blakemore & Son Ltd (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary A.F. Blakemore & Son Ltd (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Dong-A Socio Holdings Co Ltd (000640)：製薬・医療：M&Aディール及び事業提携情報
    Summary Dong-A Socio Holdings Co Ltd (Dong-A Socio Holdings), formerly Dong-A Pharmaceutical Co., Ltd., offers business management services. It is a subsidiary of Dong-A Socio Group. It operates in various markets such as pharmaceuticals, food and beverages, logistics, IT, and materials. The group f …
  • Halozyme Therapeutics Inc (HALO)：製薬・医療：M&Aディール及び事業提携情報
    Summary Halozyme Therapeutics Inc (Halozyme) is a biotechnology company that develops and commercializes novel recombinant human enzymes to provide innovative products for cancer, dermatology, diabetes and drug delivery markets. The company’s marketed product, Hylenex is an agent for drug and fluid …
  • The Bidvest Group Ltd：企業のM&A・事業提携・投資動向
    The Bidvest Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Bidvest Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Statkraft AS：企業の戦略・SWOT・財務分析
    Statkraft AS - Strategy, SWOT and Corporate Finance Report Summary Statkraft AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Mustek Ltd (MST)：企業の財務・戦略的SWOT分析
    Mustek Ltd (MST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Ceapro Inc (CZO)：製薬・医療：M&Aディール及び事業提携情報
    Summary Ceapro Inc (Ceapro) is a biotechnology company which develops proprietary extraction technologies for use in the production of extracts and active ingredients from oats and other renewable plant resources. The company’s extracts are also used in nutraceutical, cosmeceutical, and therapeutics …
  • Tennessee Valley Authority：企業の戦略的SWOT分析
    Tennessee Valley Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • CryoPort Inc (CYRX)：企業の財務・戦略的SWOT分析
    CryoPort Inc (CYRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Robert Half International Inc (RHI)：企業の財務・戦略的SWOT分析
    Robert Half International Inc (RHI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆